• Skip to main content
  • Skip to after header navigation
  • Skip to site footer

Free-Mail

  • Events
  • Images
    • Instagram Goodness
  • Music
  • News
  • Software

antibody

The WHO has advised against the use of two antibody therapies against COVID – here’s what that means

The WHO has advised against the use of two antibody therapies against COVID – here’s what that means: Sotrovimab and casirivimab-imdevimab are no longer recommended for patients with COVID. ice_blue/Shutterstock New guidance from the World Health Organization (WHO) strongly advises against using the antibody therapies sotrovimab and casirivimab-imdevimab to treat patients with COVID-19. This guidance, …

Read moreThe WHO has advised against the use of two antibody therapies against COVID – here’s what that means

COVID: new antibody treatment could offer up to 18 months’ protection against severe disease

COVID: new antibody treatment could offer up to 18 months’ protection against severe disease: Antibodies (light blue) binding to the spike proteins (dark purple) on the outside of the coronavirus. Design_Cells/Shutterstock A new treatment could soon help protect people from developing severe COVID. AstraZeneca has just released results from a phase 3 clinical trial – …

Read moreCOVID: new antibody treatment could offer up to 18 months’ protection against severe disease

Mixed AstraZeneca-Pfizer shot boosts COVID antibody level – study

South Africa in the news: Mixed AstraZeneca-Pfizer shot boosts COVID antibody level – study: A mixed vaccination of first AstraZeneca and then a Pfizer COVID-19 shot boosted neutralizing antibody levels by six times compared with two AstraZeneca doses, a study from South Korea showed. The …: “South Africa” – BingNews WWC21 – SeaHorse, Israel: I’ll …

Read moreMixed AstraZeneca-Pfizer shot boosts COVID antibody level – study

COVID: study finds lower antibody activity against delta variant at single dose – but vaccines still work

COVID: study finds lower antibody activity against delta variant at single dose – but vaccines still work: NIAID/Wikimedia Commons, CC BY Chris Whitty, the chief medical officer for England, recently announced that the delta variant is no longer of concern because it now comprises 98% of new cases in the country and is therefore “the …

Read moreCOVID: study finds lower antibody activity against delta variant at single dose – but vaccines still work

How Covid variants turns more infectious, antibody resistant

South Africa in the news: How Covid variants turns more infectious, antibody resistant: US researchers have identified how multiple mutations on the SARS-CoV-2 spike protein independently create variants that are more transmissible and …: “South Africa” – BingNews Silence Isn’t Neutral: Gwen Berry hurled a hammer more than 241 feet during Saturday’s track and field …

Read moreHow Covid variants turns more infectious, antibody resistant

GlaxoSmithKline-Vir COVID-19 Antibody Drug Granted EUA In U.S.

South Africa in the news: GlaxoSmithKline-Vir COVID-19 Antibody Drug Granted EUA In U.S.: The U.S. Food and Drug Administration has granted an emergency use authorization for a COVID-19 antibody drug made by GlaxoSmithKline …: “South Africa” – BingNews Mehalhel retains control of Weightlifting Federation of Africa: Khaled Mehalhel has been re-elected for a third term …

Read moreGlaxoSmithKline-Vir COVID-19 Antibody Drug Granted EUA In U.S.

Autoimmune-disease drugs may reduce vaccine response; antibody treatments ineffective vs Brazil variant

South Africa in the news: Autoimmune-disease drugs may reduce vaccine response; antibody treatments ineffective vs Brazil variant: This suggests that the Brazil variant might not pose as great a threat of reinfection or decreased vaccine protection as the South Africa variant, said coauthor David Ho from Columbia University. Real …: “South Africa” – BingNews On …

Read moreAutoimmune-disease drugs may reduce vaccine response; antibody treatments ineffective vs Brazil variant

Mapping Which Coronavirus Variants Will Resist Antibody Treatments

South Africa in the news: Mapping Which Coronavirus Variants Will Resist Antibody Treatments: Caption: The antibody LY-CoV016 (purple) is bound to RBD. This “escape map” indicates where in the viral RBD new mutations are most likely to make LY-CoV016 less effective (red). It also shows places …: “South Africa” – BingNews Moody’s sends downgrade warning …

Read moreMapping Which Coronavirus Variants Will Resist Antibody Treatments

Coronavirus morning update: Alcohol sales ban ‘fake news’, and Covid-19 antibody tests now legal

South Africa in the news: Coronavirus morning update: Alcohol sales ban ‘fake news’, and Covid-19 antibody tests now legal: Rumours alleging the ban on the sale of alcohol was to be be reinstated not true; and the national Department of Health has confirmed that antibody testing is now legal.: “South Africa” – BingNews Global 3 …

Read moreCoronavirus morning update: Alcohol sales ban ‘fake news’, and Covid-19 antibody tests now legal

Antibody tests aren’t a COVID-19 panacea. But they’re a useful additional tool

Antibody tests aren’t a COVID-19 panacea. But they’re a useful additional tool: MSF nurse, Bhelekazi Mdlalose, performs a swab test for coronavirus on a health worker in Johannesburg. As the COVID-19 pandemic escalates, South Africa is struggling to keep up with the demand for testing. This has pushed laboratory professionals and clinicians to consider using …

Read moreAntibody tests aren’t a COVID-19 panacea. But they’re a useful additional tool

Coronavirus: the antibody drugs few people have been discussing – until now

Coronavirus: the antibody drugs few people have been discussing – until now: Since the start of the COVID-19 pandemic, researchers have been working around the clock to find an effective treatment. The first drug to show promise is dexamethasone, a cheap, widely available steroid. A large clinical trial run by the University of Oxford showed …

Read moreCoronavirus: the antibody drugs few people have been discussing – until now

Alzheimer’s disease: we designed an antibody to detect toxic particles in the brain

Alzheimer’s disease: we designed an antibody to detect toxic particles in the brain: This antibody could be used to develop future treatments. Orawan Pattarawimonchai/ Shutterstock Alzheimer’s disease is the major cause of dementia, which affects more than 50 million people worldwide. This disease is still incurable, as we don’t know yet how to stop it, …

Read moreAlzheimer’s disease: we designed an antibody to detect toxic particles in the brain

Reach Trust

Reach Trust is a holding trust for a number of companies within the Stratlec Group.

Copyright © 2026 · Free-Mail · All Rights Reserved · Powered by Straton Electrical

Back to top